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Abstract
Antibody prevalence studies in laboratory mice indicate that murine norovirus (MNV) infections are common, but the
natural history of these viruses has not been fully established. This study examined the extent of genetic diversity of murine
noroviruses isolated from healthy laboratory mice housed in multiple animal facilities within a single, large research
institute- the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH) in
Bethesda, Maryland, U.S. Ten distinct murine norovirus strains were isolated from various tissues and feces of asymptomatic
wild type sentinel mice as well as asymptomatic immunodeficient (RAG 2
2/2) mice. The NIH MNV isolates showed little
cytopathic effect in permissive RAW264.7 cells in early passages, but all isolates examined could be adapted to efficient
growth in cell culture by serial passage. The viruses, although closely related in genome sequence, were distinguishable
from each other according to facility location, likely due to the introduction of new viruses into each facility from separate
sources or vendors at different times. Our study indicates that the murine noroviruses are widespread in these animal
facilities, despite rigorous guidelines for animal care and maintenance.
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Introduction
Noroviruses, members of the virus family Caliciviridae, are
ubiquitous enteric viruses found in a broad range of animal
species, including mice [1]. In humans, they are associated with
nausea, vomiting, diarrhea, and fever that characteristically last
approximately 24–48 hours. They are transmitted via person-to-
person contact, or by exposure to contaminated food or water.
Outbreaks often occur in settings such as nursing homes and cruise
ships, where close contact allows for easy spread of the virus. Long-
term illness and shedding of noroviruses have been reported in
immunocompromised individuals [2]. The approximately 7.6 kb
positive-sense, single-stranded RNA genome of norovirus is
organized into three major open-reading frames (ORFs): ORF1
encodes a large polyprotein that is cleaved into nonstructural
precursors and proteins involved in viral replication; ORF2
encodes the major capsid protein, VP1; and ORF3 encodes a
minor structural protein of the virion, VP2 [3,4,5,6]. In murine
norovirus (MNV) strains [7], an additional ORF4 has been
described that encodes a protein of unknown function [8].
Noroviruses have been divided into five distinct genogroups (GI–
GV) [9], with human pathogens belonging to GI, GII, and GIV.
The bovine and murine noroviruses detected thus far belong to
GIII and GV, respectively. Although genetically distinct from the
human noroviruses, the murine noroviruses have emerged as an
important model in the study of norovirus biology and replication
because, in contrast to the human pathogens, an efficient cell
culture system is available [10,11].
The discovery of the first MNV strain, designated MNV-1, in
mice within a U.S. university research facility [7] led to the
development of antibody detection assays that quickly showed
serologic evidence for a widespread distribution of this virus in
laboratory mice [12]. Although most mice infected with MNV
appear healthy, the viruses have been associated with severe
systemic illness and death in certain genetically engineered mice
lacking an intact innate immune system such as STAT1
2/2 mice
[7]. The MNV strains characterized thus far have formed a highly
related single genotype within GV, whether associated with
asymptomatic infection or disease [8], but recombination events
between viruses have been proposed [13]. At our research
institute, the National Institute of Allergy and Infectious Diseases
(NIAID) of the National Institutes of Health (NIH), U.S., serologic
evidence for MNV infection was found in several ‘‘sentinel’’ mice
in various animal rooms [14,15], which prompted us to examine
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We isolated murine noroviruses in cell culture from ten NIH mice
and the genomes of these viruses were sequenced. The MNV
strains characterized within each NIAID animal facility were
distinct from those in other facilities of the institute, suggesting the
introduction of the virus into each facility from a separate source.
However, the NIH MNV strains showed marked overall genetic
relatedness with other murine norovirus strains detected thus far.
Results
By serologic screening of sentinel mice housed in several NIAID
animal facilities, we found evidence initially for norovirus
infection, and in addition, we were able to detect the virus by
RT-PCR in representative mice [15]. This study focused on the
further characterization of MNV strains isolated from mice housed
in three of the animal facilities (Table 1). While all facilities housed
mice from the same commercial vendors, each facility also housed
mice received from separate non-commercial sources. Ten MNV
strains (designated as the NIH strains) were isolated following
passage in RAW264.7 cells, and their full-length genomes were
sequenced. The genomes were similar in length (7382 or 7383 nt)
and organized into three major open reading frames (ORFs):
ORF1 (nt 6–5069) encoding the nonstructural polyprotein, ORF2
(nt 5056–6681) encoding the major capsid protein, VP1, and
ORF3 (nt 6681–7307) encoding the minor capsid protein, VP2
(Figure 1). In addition, the genomes contained a predicted
conserved fourth ORF (ORF4) spanning nt 5069–5710 that
would encode a putative protein of 23.6 kDa [8].
Comparison of the nucleotide sequences showed a close genetic
relationship among the NIH MNV strains, with a range of 87.2–
99.7% overall nucleotide identity. The nucleotide identities with
the prototype strain, MNV-1, ranged from 87.4–89.1%, and with
all other full-length MNV sequences available in GenBank, the
identities ranged from 87.4–99%. Comparison of the deduced
amino acid sequences among the NIH strains showed that the
proteinase was the most highly conserved protein (approximately
97% similarity), while the VP1 (major capsid protein) showed the
most variability (as low as 89.6% similarity). Analysis of the MNV-
1 VP1 capsid protein showed that the shell (S) region of the capsid
protein (amino acid residues 49 to 218) was 100% conserved
among the NIH MNV strains while the protruding (P) region
(amino acids 229 to 537) was most variable, consistent with data
reported for other highly-related murine noroviruses [8]. The P2
domain (amino acids 278–415) within the P region is exposed
predominantly on the surface of the virion and has been proposed
as the major site of immune pressure and receptor binding for
calicivirus virions [16]. Consistent with this, passage of the virulent
MNV-1 strain in cell culture yielded virus in which lysine was
changed to glutamic acid at position 296 in the P2 domain. This
single amino acid substitution resulted in loss of virulence of the
MNV-1 strain in STAT1-deficient mice (17). Of interest, a
glutamic acid residue at position 296 was conserved in the cell-
culture adapted NIH MNV strains in this study, as well as the
NIH-2409 virus prior to adaptation (data not shown) [17]. A
leucine residue at position 386 involved in the formation of a
neutralization epitope in MNV-1 [18] was conserved in the P2
domain of the NIH MNV strains (data not shown).
The replication strategy for murine norovirus involves the
proteolytic processing of the ORF1 polyprotein into several
nonstructural proteins by the virus-encoded cysteine proteinase
(Pro). The proteinase mediates five cleavages at dipeptide sites
341E/G
342,
705Q/N
706,
870E/G
871,
994E/A
995, and
1177Q/G
1178 to
produce six proteins: NS1-2 (Nterm), NS3 (NTPase), NS4 (p18),
NS5 (VPg), NS6 (Pro) and NS7 (Pol) [6]. Alignment of the
deduced ORF1 polyprotein sequences of the NIH MNV strains
with that of MNV-1 showed that these dipeptide cleavage sites
were conserved in location, but with some minor variation in the
P19 positions at amino acid residues 706 and 871 (Figure 1).
A phylogenetic analysis of the complete genome sequences of
the NIH MNV strains was performed to compare their relatedness
with that of other murine noroviruses (Figure 2). The NIH strains
clustered with Genogroup V murine noroviruses, but did not share
complete identity with other strains reported thus far. Eight of the
strains formed a distinct monophyletic group (NIH- 4421, 2747,
2409, 2411, 2410, 2750, 4428, and 4431, with nucleotide variation
not exceeding 1%). Strain NIH-A114 did not cluster with other
viruses and formed a distinct branch. Strain NIH-D220 clustered
most closely with a phylogenetic group that included several
Charles River (CR) and Washington University (WU) strains. The
three genetic groupings of the NIH strains corresponded to their
isolation from three distinct animal facilities in the institute at
different times (Table 1).
A previous study had identified amino acid substitutions in the
NS4 and VP1 proteins that emerged during cell-culture passage of
Table 1. Murine norovirus strains isolated from NIH mice.
Strain Designation NIH Facility Mouse Specimen Passage (P)
Strain Source for Virus Number*
Mu/NoV/GV/NIH- 2409/2005/US B14 RAG22/2 MLN P0, P1, P2, 3xPP
Mu/NoV/GV/NIH -2410/2005/US B14 RAG22/2 MLN P3
Mu/NoV/GV/NIH- 2411/2005/US B14 RAG22/2 MLN P3
Mu/NoV/GV/NIH- 2747/2005/US B14 RAG22/2 MLN P3
Mu/NoV/GV/NIH- 2750/2005/US B14 RAG22/2 MLN P3
Mu/NoV/GV/NIH -4421/2005/US B14 RAG22/2 Duodenum P3
Mu/NoV/GV/NIH -4428/2005/US B14 RAG22/2 Duodenum P3
Mu/NoV/GV/NIH-4431/2005/US B14 RAG22/2 Duodenum P4
Mu/NoV/GV/NIH -A114/2006/US TB Swiss Webster Fecal P7
Mu/NoV/GV/NIH-D220/2007/US B50 Swiss Webster Fecal P2
*Passage (P) number of virus in RAW264.7 cells at which genome sequence was determined as described in text.
doi:10.1371/journal.pone.0021435.t001
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MNV NIH-2409 during cell culture passage to examine whether
similar substitutions occurred. Strain NIH-2409 was isolated from
a RAG2
2/2 mouse in a facility (B14) that has operated for more
than 20 years, and that accepts vendor animals and transfer
animals from within NIH as well as imported animals. The
mesenteric lymph node tissue was homogenized and added to a
monolayer of RAW264.7 cells and incubated for 7 days. There
was no visible cytopathic effect (CPE) in RAW264.7 cells following
the initial 7-day infection period. However, an immunofluores-
cence assay showed the presence of occasional cells with a
perinuclear, localized area of positive reactivity with the MNV-1-
specific antibodies (as indicated by arrows in Figure 3A) that was
not present in the mock-infected RAW264.7 cells (Figure 3B). The
passage 1 (P1) material was added to a new monolayer and the
visible CPE increased with each subsequent cell passage. After
three passages, the material was subjected to plaque purification,
and small plaques were observed (Figure 3C). Following two
additional rounds of plaque purification (selecting large plaques),
the plaque morphology resembled MNV-1 (Figure 3D).
The ‘‘consensus sequence’’ of the genome of the virus in the
original MLN specimen (P0) was determined by the direct
sequencing of RT-PCR products that spanned the genome. Only
a few nucleotide changes were observed between the first two
serial passages (P1 and P2) and after three rounds of plaque
purification (3xPP), consistent with previous studies of MNV-1
[11] (Table 2). At nucleotide position 2166, a mixed population
was detected that would result in either a serine or alanine at
amino acid residue 721 in the NS4 region of the ORF1
polyprotein. Following three rounds of plaque purification of P3,
an alanine became the predominant sequence at position 721. Of
note, no adaptive amino acid mutations were observed in the VP1
(capsid) protein for this strain.
Discussion
Murine noroviruses are associated with asymptomatic infection
and shedding in many mouse strains (both normal and genetically-
modified), making the viruses difficult to detect in animals without
active screening [13]. We investigated the characteristics of several
murine norovirus strains within our research institute (NIAID) in
order to gain insight into norovirus diversity and natural history
within a single setting. A real-time qRT-PCR assay [19] that
readily detects MNV strains in mice housed in the NIAID animal
facilities in Hamilton, Montana (data not shown) proved efficient
in the detection of MNV strains in Maryland. Ten unique MNV
strains (designated MNV NIH) were isolated from tissue and stool
samples collected from asymptomatic laboratory mice that were
housed in rooms with MNV-positive sentinel mice. The ten NIH
murine norovirus strains clustered within Genogroup V, similar to
all MNV strains characterized thus far. However, the strains fell
into three distinct lineages within Genogroup V. Viruses isolated
from mice within the same NIAID facility were distinct compared
with those from mice in other facilities on campus. This
observation suggests that strains are introduced independently
from different sources as they are brought into each animal facility
of the institute.
One MNV strain (NIH-2409) was selected for additional
analyses in order to identify mutations in the genome involved
in cell culture adaptation. Unlike MNV-1, which was highly
cytopathic upon its initial isolation in cell culture [10], strain MNV
NIH-2409 did not cause visible CPE in early passages.
Interestingly, a single amino acid change was detected in the
NS4 (‘‘3A-like’’) protein following adaptation. Serine was the
predominant amino acid at residue 721 in viral RNA purified
from the original lymph node tissue, but alanine was the
predominant amino acid residue after passage and plaque
purification. This variation was similar in location to an amino
acid residue (position 716) that changed from valine to isoleucine
in NS4 of the MNV-1 strain following passage in RAW264.7 cells
[10]. The function of the NS4 protein has not been determined,
but it is likely that this protein may play a role in interactions with
host cells. The majority of the synonymous (silent) nucleotide
mutations during cell culture passage occurred in ORF1 and
ORF2 in both NIH-2409 and MNV-1. Strain NIH-2409 showed
no changes in ORF3 during serial passage, while MNV-1
Figure 1. Sequence analysis of NIH MNV strains. Genome organization of prototype strain MNV-1 [7] and ORF1 polyprotein cleavage sites [6] in
comparison with the predicted cleavage sites in the ORF1 polyprotein of the NIH murine norovirus strains. Dipeptide recognition sites that differ from
MNV-1 are indicated in bold type.
doi:10.1371/journal.pone.0021435.g001
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plaque purification.
It is not clear when MNV was introduced into laboratory mice,
and whether such strains circulate in wild mice. Recent studies of
experimental mouse models found that the presence of MNV did
not affect the immune response and recovery from Friend
retrovirus [19], or the development of adaptive immunity to
vaccinia virus and influenza virus [20]. Murine norovirus did not
affect experimental outcomes from murine cytomegalovirus
infection, although there was a decreased CD8 T cell response
[21]. However, the presence of MNV did increased the length of
time have an effect on parvovirus was shedding in Balb/c mice
[22] and concerns have been raised for its effect in other murine
disease models [23,24,25]. Sequence analysis of the new MNV
NIH strains described in this study contributes to the growing
database of genomic norovirus sequences. Continued analysis of
the molecular epidemiology of these viruses should give insight
into their natural history and evolution in mice.
Materials and Methods
Cells and viruses
The murine macrophage-like cell line RAW264.7 was obtained
from American Type Culture Collection (Manassas, VA). The
cells were grown in Dulbecco’s Modified Eagle’s Medium
(DMEM) supplemented with penicillin (250 units/ml), streptomy-
cin (250 mg/ml), 1% glutamine, and 10% heat-inactivated fetal
calf serum. Murine norovirus strain MNV-1 [7] was a gift of Dr.
Herbert Virgin, Washington University, Saint Louis, MO.
Mesenteric lymph node (MLN), hepatic, spleen or duodenal
tissues and fecal samples were collected from mice housed in three
different NIAID animal facilities on the NIH, Bethesda, Maryland
campus [15] (Table 1) under a protocol approved by the NIAID
Animal Care and Use Committee. Sentinel mice in these facilities
were routinely monitored for serological evidence of infection with
several agents, including MNV, and all three facilities reported
MNV antibody-positive sentinel mice. Fifty ml of the filtered tissue
or fecal suspension was added to a RAW264.7 cell monolayer
seeded in one well of a 6-well tissue culture plate (Costar, Corning
Inc., Corning, NY), after which the cells were incubated for 5–7
days at 37uC. Cells were then frozen and thawed and 50 ml of the
resultant suspension was used to infect a new RAW264.7 cell
monolayer. The material was passed between 2 and 7 times,
depending on the amount of associated CPE. Fluid from the final
passage was collected and subjected to three rounds of plaque-
purification. A plaque from the third purification was isolated and
amplified to serve as a virus stock for sequence analysis of the
complete genome.
Tissue culture adaptation of MNV strain NIH-2409
An MLN homogenate from mouse 2409 was added to
RAW264.7 cells in two wells of a 6-well plate. The material from
one well was passed three times in RAW264.7 cells as described
above. The second well was fixed with methanol and the presence
of MNV antigen after 7 days was examined by immunofluores-
cence assay as described below. Following pass 3 (P3), the isolated
MNV strain, designated NIH-2409, was plaque-purified three
times (3XPP). Briefly, a plaque was removed from the monolayer
Figure 2. Phylogenetic analysis of NIH MNV viral genomes in comparison with representative viruses previously published.
Phylogenetic relationships were inferred using Neighbor-joining method, with the evolutionary distances computed by the Tamura-Nei method. The
statistical support for tree nodes was evaluated by bootstrap analysis (500 replicates) and values higher than 65 are shown above the corresponding
branches. The strains in this analysis and their GenBank accession numbers are shown in the Supplemental Table (Table S1).
doi:10.1371/journal.pone.0021435.g002
Figure 3. Serial passage of MNV NIH-2409 in RAW264.7 cells. A. Immunofluorescence assay of RAW264.7 cells inoculated directly with a
lymph node homogenate from mouse. Medium was removed after 7 days, cells were fixed with methanol, and viral antigen expression was detected
with anti-MNV-1 VP1 serum. Representative positive MNV antigen expression is indicated by white arrows. B. Mock-infected RAW264.7 cells
incubated with same serum. C. First plaque purification of NIH MNV-2409 following P3 in RAW264.7 cells as described in Material and Methods.
D. Plaque morphology after two additional plaque purifications in RAW264.7 cells (3XPP virus stock).
doi:10.1371/journal.pone.0021435.g003
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to a second plaque-purification. A second plaque was removed,
diluted in medium, and subjected directly to a third plaque
purification. The final isolated plaque was amplified in cells and
the virus stock was designated 3XPP. The consensus sequence of
the genome of the virus present in the original tissue (P0) was
determined and compared to that of the virus obtained at P1, P2,
and after three rounds of plaque purification (3XPP).
RNA extraction
Tissue samples were placed in 0.5 ml sterile, cold phosphate
buffered saline (PBS) and disrupted on ice with either a Dounce
homogenizer or an electric high shear tissue homogenizer (Omni
International, Kennesaw, GA). Tissue suspensions were then
stored at 270uC. Fecal pellets were added to PBS at a
concentration of approximately 10% w/v in a sterile microfuge
tube, followed by vortexing. The solid material in the feces was
pelleted by low-speed centrifugation (10,000 rpm610 minutes) in
a tabletop microfuge and the clarified fecal suspension was filtered
and transferred to a sterile microfuge tube. Viral RNA was
extracted with the QIAamp Viral RNA mini kit (Qiagen,
Valencia, CA) using a 100 ml aliquot of either the fecal or tissue
suspension. The extracted RNA was eluted in 50 ml of RNase-free
water and stored at 270Cu.
Sequence analysis of RT-PCR products
The purified RNA was amplified by RT-PCR with the One
Step RT-PCR kit (Invitrogen, Carlsbad, CA) in a strategy that
produced seven amplicons that were gel-purified and sequenced
directly (primers for RT-PCR shown in Table 3). Sequencing was
performed with the BigDye Terminator v.3.1 cycle Sequencing
Ready Reaction kit in an AB1 3100 Automated sequencer
(Applied Biosystems, Foster City, CA). The precise ends of the
genome were determined with the 59 and 39 Rapid Amplification
of cDNA Ends (RACE) systems from Invitrogen.
Phylogenetic analysis
Multiple sequence alignments were generated with the ClustalW
algorithm in the MacVector, Inc. (Cary, NC) software package.
Phylogenetic relationships were inferred using the Neighbor-joining
method [26], with the evolutionary distances computed by the
Tamura-Nei method [27]. The statistical support for tree nodes was
evaluated by bootstrap analysis (500 replicates) [28]. Evolutionary
analyses were conducted with the MEGA software package [29].
qRT-PCR detection assay
A real-time qRT-PCR assay was adapted for the detection of
MNV RNA [19,30]. Briefly, a forward primer 59-AATC-
TATGCGCCTGGTTTGC-39 and a reverse primer 59-CTCAT-
CACCCGGGCTGTT-39were employedtoamplifyaregionofthe
genome corresponding to nucleotides (nt) 5585–5646. A Taqman
probe with the sequence 59-CACGCCACTCCGC-39 (correspond-
ingtont5613–5625 oftheMNV NIH-2409genome)wasgenerated
withFAM dyelinkedtothe59-end and BHQ dyeatthe39-end. Five
ml of RNA were added to an RT-PCR mix (Brilliant II qRT-PCR
core reagent kit, Stratagene, La Jolla, CA). The reaction was then
incubated at 45uC for 30 min, 95uC for 10 min, followed by 45
cycles at 95uC for 30 sec, 50uC for 1 min and 72uC for 30 sec in an
ABI 7900 HT instrument (Applied Biosystems). Each sample was
tested in duplicate and an appropriate triplicate standard curve for
absolute quantification was included in each run.
Immunofluorescence
RAW264.7 cells were infected with virus and incubated 7 days
before fixation with cold methanol (100%). The methanol was
removed and the cells were rinsed with PBS, pH 7.4. Hyperim-
Table 2. Sequence analysis of viral genomes during passage of MNV NIH-2409 in cell culture.
Open Reading
Frame (ORF) Protein
Genomic
Position of
Nucleotide
Position of
Amino Acid Amino Acid
2409 Lymph
Node (Pass 0) 2409 Pass 1 2409 Pass 2
2409 Pass 3
after plaque
purification (3xPP)
ORF1 NS1-2 188 61 Ala GCAG C A/GCGG C G/GCAG C A
NS1-2 320 105 Ala GCCG C TG C TG C C
NS1-2 629 208 Pro CCCC C TC C TC C C
NS3 1469 488 Arg CGT/CGC CGC/CGT CGC/CGTC G C
NS3 1487 494 Arg CGG/CGAC G A/CGGC G A/CGGC G A
NS3 1817 604 Thr ACT/ACCA C C/ACTA C C/ACTA C C
NS3 2081 692 Val GTC/GTTG T T/GTCG T C/GTTG T C
NS4 2166 721 SerRAla TCC/GCC GCC/TCC TCC/GCC GCC
NS4 2495 830 Tyr TACT A T/TACT A C/TATT A T
NS4 2531 842 Tyr TACT A T/TACT A C/TATT A C
NS4 2543 846 Gly GGT/GGCG G T/GGCG G T/GGCG G T
NS7 3803 1266 Val GTT/GTCG T C/GTTG T C/GTGG T C
NS7 3809 1268 Asp GAT/GACG A T/GACG A T/GACG A C
NS7 4151 1382 Phe TTC/TTTT T C/TTTT T T/TTCT T C
ORF2 VP1 5481 142 Thr ACAA C G/ACAA C A/ACGA C G
VP1 5892 279 Thr ACG/ACCA C GA C GA C G
VP1 5904 283 Gly GGC/GGTG G CG G CG G C
VP1 6550 499 Leu TTG CTG/TTG TTG/CTG CTG
Note: Positions with variation in sequence are underlined.
doi:10.1371/journal.pone.0021435.t002
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VP1 [14] was added at a 1:100 dilution and incubated at 37uC for
one hour. The wells were then rinsed three times with PBS, and
affinity purified goat antibodies specific for guinea pig immuno-
globulin G (IgG) (ICN Biomedicals, Aurora, OH) and conjugated
to fluorescein isothiocyanate were added at a 1:20 dilution to
detect binding of the primary antibody.
Supporting Information
Table S1 Murine norovirus strains included in phylogenetic
analysis and their GenBank accession numbers are shown.
(XLSX)
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